StockData
Estrella Immunopharma, Inc. logo

Estrella Immunopharma, Inc. (ESLA) KPIs and segments

ESLANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ESLAW
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.33−0.05 (-12.74%)

Close on Nov 17, 2026Market cap $14.42MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Estrella Immunopharma's business

Coming soon

This tab will track the numbers specific to Estrella Immunopharma's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?